Cantourage Group SE

Equities

HIGH

DE000A3DSV01

Drug Retailers

Real-time Estimate Tradegate 07:34:09 24/05/2024 pm IST 5-day change 1st Jan Change
7.175 EUR +1.77% Intraday chart for Cantourage Group SE +0.69% +1.67%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
WDH/Survey: Seven percent of adults have bought cannabis seeds DP
Cannabis law signed - release on April 1 DP
Controversial cannabis law has been signed DP
TOTAL Federal Council paves the way for growth package and cannabis DP
Federal Council clears the way for cannabis legalization DP
Synbiotic continues to rise after cannabis legalization DP
Circles/Cannabis dispute: Hesse wants to abstain in the Bundesrat DP
Cannabis dispute: Baden-Württemberg in favor of mediation committee DP
Synbiotic corrects after cannabis rally - legalization open DP
Daniel Günther: Cannabis law to be postponed until October DP
Cannabis dispute: Baden-Württemberg calls for mediation committee DP
Cannabis law and clinic atlas in the Bundesrat DP
Dreyer does not expect cannabis law to fail DP
Drugs commissioner lobbies states for cannabis law DP
Union interior ministers want to consider legal action against cannabis legalization DP
Bundestag approves controlled cannabis release DP
Synbiotic share price fireworks continue - cannabis approval imminent DP
Bundestag decides on cannabis and naval deployment DP
Greens: Cannabis legalization overdue - CDU/CSU: Historic mistake DP
Legislative plans for cannabis legalization in committee DP
Lauterbach defends cannabis approval - further criticism DP
Juvenile court judge Müller warns against scaremongering on cannabis DP
SHARES IN FOCUS 2: Synbiotic and Cantourage rally - risk of correction feared DP
SHARES FOCUS: Cannabis legalization drives Synbiotic and Cantourage upwards DP
Cantourage Group SE Provides Earnings Guidance for the Fiscal Year 2023 CI
Chart Cantourage Group SE
More charts
Cantourage Group SE is a Germany-based holding company. The Company offers products in market segments such as: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol, through Cantourage GmbH and its subsidiaries. The object of Cantourage GmbH is the production of and wholesale trade in cannabis-based medicinal preparations and trade in other cannabis products.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.05 EUR
Average target price
10 EUR
Spread / Average Target
+41.84%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. HIGH Stock
  4. News Cantourage Group SE
  5. Cantourage Group Collaborates with Canadian Cannabis Company Green Karat